Grupo farmacéutico · Reino Unido
AstraZeneca
Un grupo de 50 empresas con 937 medicamentos en 12 países.
Estructura del grupo
50 empresas en 19 países
Cargando la página…
Cargando la página…
Grupo farmacéutico · Reino Unido
Un grupo de 50 empresas con 937 medicamentos en 12 países.
50 empresas en 19 países
Una cuenta gratuita para las apps de Prognia: Ward para estudiar, Osler para respuestas clínicas con sus fuentes y la red para encontrar a tus colegas.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Todos los medicamentos de todas las empresas del grupo, primero los vigentes.
1–25 de 937
| Medicamento | Principio activo | País | Estado | Autorización |
|---|---|---|---|---|
| AIRSUPRA0.09mg base/inh; 0.08mg/inh · Aerosol, metered | Salbutamol, Budesonide | Estados Unidos | Comercializado | 2023 |
| AQUASOL A25,000usp units | 50,000usp units · Capsule | Vitamin a | Estados Unidos | No comercializado | |
| ARDECTO | Dapagliflozina propanodiol, Saxagliptin | Brasil | Autorizado | 2021 |
| ARIMIDEX1 mg · Tablet | Anastrozole | Canadá | Comercializado | 1996 |
| ARIMIDEX | Anastrozole | Brasil | Autorizado | 1996 |
| ARIMIDEX TABLET 1 mg1 mg · Tablet, film coated | Anastrozole | Singapur | Autorizado | 1997 |
| BAXFENDY1mg | 2mg · Tablet | Baxdrostat | Estados Unidos | Comercializado | 2026 |
| BEVESPI AEROSPHERE0.0048mg/inh; 0.0090mg/inh · Aerosol, metered | Formoterol, Glycopyrronium | Estados Unidos | Comercializado | 2016 |
| Bevespi Aerosphere | Glycopyrronium, Formoterol | UE (EMA) | Autorizado | 2018 |
| BEVESPI AEROSPHERESospensione pressurizzata per inalazione | Glycopyrronium, Formoterol | Italia | Autorizado | |
| Bevespi Aerosphere 7,2 micrograms/5,0 micrograms, Aërosol, suspensieAërosol, oplossing | Formoterol, Glycopyrroniumbromide | Países Bajos | Autorizado | 2018 |
| BEVESPI AEROSPHERE® | Brometo glicopirrônio, Formoterol | Brasil | Autorizado | 2020 |
| BEYFORTUS100mg | 50mg · Injectable | Nirsevimab | Estados Unidos | Comercializado | 2023 |
| BREZTRI AEROSPHERE0.16mg/inh; 0.0048mg/inh; 0.009mg/inh | 0.16mg/inh; 0.0048mg/inh; 0.018mg/inh · Aerosol, metered | Budesonide, Formoterol, Glycopyrronium | Estados Unidos | Comercializado | 2020 |
| BREZTRI AEROSPHERE | Budesonide, Brometo glicopirrônio, Formoterol | Brasil | Autorizado | 2024 |
| BREZTRI AEROSPHERE160 mcg / act + 5 mcg / act + 7.2 mcg / act · Aerosol (Metered-Dose) | Budesonide, Formoterol, Glycopyrronium | Canadá | Comercializado | 2021 |
| BREZTRI AEROSPHERE PRESSURISED INHALATION SUSPENSION 160 MCG/7.2 MCG/5 MCG per actuation160 μg/actuation + 5.0 μg/actuation + 7.2 μg/actuation · Aerosol, metered | Budesonide, Formoterol, Glycopyrronium | Singapur | Autorizado | 2023 |
| Bricanyl 250 Turbuhaler, inhalatiepoeder 250 microgram/dosisInhalatiepoeder | Terbutaline | Países Bajos | Autorizado | 1993 |
| Bricanyl 500 Turbuhaler, inhalatiepoeder 500 microgram/dosisInhalatiepoeder | Terbutaline | Países Bajos | Autorizado | 1988 |
| BRICANYL TURBUHALER0.5 mg / dose · Powder | Terbutaline | Canadá | Comercializado | 1990 |
| BRILINTA60 mg · Tablet | Ticagrelor | Canadá | Comercializado | 2016 |
| BRILINTA90 mg · Tablet | Ticagrelor | Canadá | Comercializado | 2011 |
| BRILINTA60mg | 90mg · Tablet | Ticagrelor | Estados Unidos | Comercializado | 2011 |
| BRILINTA | Ticagrelor | Brasil | Autorizado | 2010 |
| BRILINTA TABLET 60 MG60 mg · Tablet, film coated | Ticagrelor | Singapur | Autorizado | 2017 |
Dónde es titular o fabricante de medicamentos, y cuántos están vigentes.
| País | Medicamentos | Vigentes | Anteriores | Empresas |
|---|---|---|---|---|
| Canadá | 153 | 73 | 80 | EmpresasTodos los medicamentos |
| Arabia Saudí | 139 | 139 | 0 | EmpresasTodos los medicamentos |
| Brasil | 135 | 51 | 84 | EmpresasTodos los medicamentos |
| España | 110 | 93 | 17 | EmpresasTodos los medicamentos |
| Estados Unidos | 99 | 97 | 2 | EmpresasTodos los medicamentos |
| Países Bajos | 77 | 77 | 0 | EmpresasTodos los medicamentos |
| Singapur | 62 | 62 | 0 | EmpresasTodos los medicamentos |
| Rumanía | 54 | 0 | 54 | EmpresasTodos los medicamentos |
| Unión Europea (EMA) | 52 | 38 | 14 | EmpresasTodos los medicamentos |
| Italia | 45 | 45 | 0 | EmpresasTodos los medicamentos |
| Croacia | 9 | 9 | 0 | EmpresasTodos los medicamentos |
| Argentina | 2 | 0 | 2 | EmpresasTodos los medicamentos |
También en los registros de Francia, Reino Unido, Serbia
Los grupos ATC a los que pertenecen la mayoría de sus medicamentos, de mayor a menor.
Los principios activos presentes en la mayoría de sus medicamentos.
Cómo lo escriben los registros, normalizado: sin forma jurídica, tildes ni mayúsculas.
Recopilado por Prognia a partir de los registros públicos de medicamentos y empresas que aparecen abajo. No se usan logotipos.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licencia: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licencia: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licencia: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licencia: Licence Ouverte v1.0
Ministerio de Salud / ANMAT, historical VNM changes, Actualizaciones del Vademecun Nacional de Medicamentos (VNM) - julio 2018, https://datos.salud.gob.ar/dataset/vademecun-nacional-de-medicamentos-vnm, CC BY 4.0, acquired 2026-10-09; structured factual adaptation.
Licencia: Creative Commons Attribution
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licencia: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licencia: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licencia: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licencia: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licencia: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licencia: BDPM exact Licence Ouverte v1.0 (October 2011)
INSEE (www.insee.fr), via DINUM API Recherche d’entreprises; include original record update date and retrieval date
Licencia: Licence Ouverte / Open Licence
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licencia: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licencia: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; October 2026 register, published 7 October 2026; https://assets.publishing.service.gov.uk/media/6ac660fdec9d3aba1e0139d9/MS_Register_-_October_2026.csv; acquired 2026-10-13T22:59:02.704630+00:00; CSV-to-role/site projection is an adaptation under Open Government Licence v3.0.
Licencia: Open Government Licence v3.0; Crown copyright MHRA factual register
GLEIF; exact source URLs/locators, version status and retrieval dates. Normalized by Prognia; no official endorsement.
Licencia: CC0
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licencia: Otvorena dozvola RH
Contains Irish Public Sector Data licensed under Creative Commons Attribution 4.0 International (CC BY 4.0), Companies Registration Office; original dataset/API URL and company number, exact locator/source version and retrieval date; selected field normalization by Prognia. https://creativecommons.org/licenses/by/4.0/
Licencia: Creative Commons Attribution
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licencia: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licencia: Italian Open Data Licence
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licencia: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Contains data under the Norwegian licence for Open Government data (NLOD) distributed by Brønnøysundregistrene. https://data.norge.no/nlod/en/2.0; original API URLs, retrieval dates and locators. Selected and normalized by Prognia; fractional JSON numbers preserved as labelled exact decimal strings.
Licencia: Norwegian Licence for Open Government Data
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licencia: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licencia: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licencia: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from ACRA Information on Corporate Entities, accessed on 8 October 2026 through Data.gov.sg, under Singapore Open Data Licence version 1.0: https://data.gov.sg/open-data-licence. Structured selection and normalisation by Prognia; original UEN, field and retrieval date retained.
Licencia: Singapore Open Data Licence
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licencia: Singapore Open Data Licence
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licencia: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Informa de un error o solicita la retiradaLas correcciones de la propia empresa son bienvenidas.
Mantenga correctos los medicamentos de AstraZeneca en Prognia, vea cómo los consultan los profesionales y responda a lo que preguntan. Una llamada de 20 minutos, en inglés.
Reservar una llamadaGrupos farmacéuticos conocidos, cada uno con todas sus empresas.
Ordenados por su número de medicamentos.